P2Y purinergic receptors regulate the growth of human melanomas

Dreiling, 1996, Melanoma: epidemiology, pathogenesis, and new modes of treatment, Adv. Intern. Med., 41, 553 Osborne, 2002, Skin cancer screening and surveillance, Br. J. Dermatol., 146, 745, 10.1046/j.1365-2133.2002.04847.x Serrone, 1999, The chemoresistance of human malignant melanoma: an update, Melanoma Res., 9, 51, 10.1097/00008390-199902000-00007 Burnstock, 2002, Purinergic signaling and vascular cell proliferation and death, Arterioscler. Thromb. Vasc. Biol., 22, 364, 10.1161/hq0302.105360 Greig, 2003, Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes, J. Invest. Dermatol., 120, 1007, 10.1046/j.1523-1747.2003.12261.x Burnstock, 1978, A basis for distinguishing two types of purinergic receptor, 107 Fredholm, 2001, International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol. Rev., 53, 527 Ralevic, 1998, Receptors for purines and pyrimidines, Pharmacol. Rev., 50, 413 Abbracchio, 1994, Purinoceptors: are there families of P2X and P2Y purinoceptors?, Pharmacol. Ther., 64, 445, 10.1016/0163-7258(94)00048-4 Burnstock, 1985, Is there a basis for distinguishing two types of P2-purinoceptor?, Gen. Pharmacol., 16, 433, 10.1016/0306-3623(85)90001-1 Khakh, 2000, P2X receptor-channels, 290 King, 2000, The P2Y receptors, 306 Berridge, 1987, Inositol trisphosphate as a second messenger in signal transduction, Ann. N.Y. Acad. Sci., 494, 39, 10.1111/j.1749-6632.1987.tb29479.x Berridge, 1995, Capacitative calcium entry, Biochem. J., 312, 1, 10.1042/bj3120001 Hoebertz, 2003, Regulation of bone resorption and formation by purines and pyrimidines, Trends Pharmacol. Sci., 24, 290, 10.1016/S0165-6147(03)00123-8 Roman, 1999, Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function, Gastroenterology, 116, 964, 10.1016/S0016-5085(99)70081-8 Rapaport, 1983, Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle, J. Cell. Physiol., 114, 279, 10.1002/jcp.1041140305 Rapaport, 1989, Generation of extracellular ATP in blood and its mediated inhibition of host weight loss in tumor-bearing mice, Biochem. Pharmacol., 38, 4261, 10.1016/0006-2952(89)90524-8 Maaser, 2002, Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors, Br. J. Cancer, 86, 636, 10.1038/sj.bjc.6600100 Janssens, 2001, Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells, Br. J. Pharmacol., 132, 536, 10.1038/sj.bjp.0703833 Schafer, 2003, ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells, Am. J. Physiol. Lung Cell. Mol. Physiol., 285, L376, 10.1152/ajplung.00447.2002 Nylund, 2004, Expression of P2Y2 purinoceptors in MCG 101 murine sarcoma cells, and HT-29 human colon carcinoma cells, Auton. Neurosci., 112, 69, 10.1016/j.autneu.2004.04.003 Merighi, 2001, Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line, Br. J. Pharmacol., 134, 1215, 10.1038/sj.bjp.0704352 Merighi, 2002, Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells, J. Invest. Dermatol., 119, 923, 10.1046/j.1523-1747.2002.00111.x Slater, 2003, Increased expression of apoptotic markers in melanoma, Melanoma Res., 13, 137, 10.1097/00008390-200304000-00005 Giard, 1973, In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J. Natl Cancer Inst., 51, 1417, 10.1093/jnci/51.5.1417 Adrian, 2000, Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells, Biochim. Biophys. Acta, 1492, 127, 10.1016/S0167-4781(00)00094-4 Gillies, 1986, Determination of cell number in monolayer cultures, Anal. Biochem., 159, 109, 10.1016/0003-2697(86)90314-3 Tulapurkar, 2004, Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5′-O-(1-boranotriphosphate) derivatives, Br. J. Pharmacol., 142, 869, 10.1038/sj.bjp.0705859 Moore, 2001, Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study, Biochim. Biophys. Acta, 1521, 107, 10.1016/S0167-4781(01)00291-3 Burnstock, 1997, The past, present and future of purine nucleotides as signalling molecules, Neuropharmacology, 36, 1127, 10.1016/S0028-3908(97)00125-1 Abraham, 2003, ATP in the treatment of advanced cancer, 415 Dubyak, 1985, Intracellular Ca2+ mobilization activated by extracellular ATP in Ehrlich ascites tumor cells, J. Biol. Chem., 260, 10653, 10.1016/S0021-9258(19)85134-7 Lin, 1993, Extracellular ATP stimulates inositol phospholipid turnover and calcium influx in C6 glioma cells, Neurochem. Res., 18, 681, 10.1007/BF00966782 Cowen, 1991, Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines, J. Leukoc. Biol., 50, 109, 10.1002/jlb.50.2.109 Popper, 1993, Calcium mobilization and cell proliferation activated by extracellular ATP in human ovarian tumour cells, Cell Calcium, 14, 209, 10.1016/0143-4160(93)90068-H Ryten, 2002, ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells, J. Cell. Biol., 158, 345, 10.1083/jcb.200202025 Chueh, 1993, Extracellular ATP stimulates calcium influx in neuroblastoma × glioma hybrid NG108-15 cells, J. Neurochem., 61, 1782, 10.1111/j.1471-4159.1993.tb09816.x Gartland, 2001, Expression of a P2X7 receptor by a subpopulation of human osteoblasts, J. Bone Miner. Res., 16, 846, 10.1359/jbmr.2001.16.5.846 Greig, 2003, Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells, J. Invest. Dermatol., 121, 315, 10.1046/j.1523-1747.2003.12379.x Katzur, 1999, Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines, J. Clin. Endocrinol. Metab., 84, 4085, 10.1210/jc.84.11.4085 Hopfner, 1998, Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells, Biochem. Biophys. Res. Commun., 251, 811, 10.1006/bbrc.1998.9555 Sellers, 2001, Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis, J. Biol. Chem., 276, 16379, 10.1074/jbc.M006617200